Novo Nordisk A/S Common Stock (NVO)
Operating Income Growth
-0.49%
TTM · Period ending:
NVO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-0.49%period ending
Latest reported-0.49%period ending
NVO TTM Operating Income YoY % (26.87% → -0.49%)
Year-over-year change
High-resolution chart · PNG
NVO operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -0.4916% | |
| 9.758% | |
| -0.5306% | |
| 12.0734% | |
| 28.118% | |
| 23.6453% | |
| 25.1185% | |
| 27.4213% | |
| 29.3538% | |
| 35.632% | |
| 37.1145% | |
| 30.1853% | |
| 29.727% | |
| 28.4354% | |
| 27.5646% | |
| 26.9951% | |
| 23.5809% | |
| 18.9429% | |
| 8.3472% | |
| 2.4936% | |
| -2.1572% | |
| -3.19% | |
| 3.1305% | |
| 6.6702% | |
| 9.237% | |
| 11.2298% | |
| 11.0798% | |
| 10.4941% | |
| 7.5819% | |
| 2.3245% | |
| -3.5105% | |
| -7.2098% | |
| -7.4433% | |
| -3.4023% | |
| 1.1046% | |
| 3.6711% | |
| 5.4079% | |
| 3.5849% | |
| -2.0468% | |
| 1.843% | |
| 8.728% | |
| 18.8015% | |
| 43.3492% | |
| 45.2354% | |
| 37.2228% | |
| 26.1294% | |
| 9.5228% | |
| 3.0841% | |
| 1.675% | |
| 4.2837% | |
| 6.8501% | |
| 13.3224% | |
| 22.7525% | |
| 31.3183% | |
| 31.7333% | |
| 35.5963% | |
| 27.681% | |
| 17.1325% | |
| 18.4374% | |
| 16.1601% | |
| 22.4538% | |
| 28.5198% | |
| 26.5051% | |
| 17.4434% | |
| 12.4252% | |
| 15.7469% | |
| 20.2857% | |
| 49.1523% | |
| 54.1153% | |
| 41.599% | |
| 38.579% | |
| 2.2347% | |
| -2.5562% | |
| -1.1324% | |
| -1.8257% | |
| 10.9923% | |
| 11.5215% | |
| 13.2948% | |
| 13.0253% | |
| 11.8197% | |
| 17.5795% | |
| 21.0459% | |
| 15.8286% | |
| 14.8717% | |
| 8.5447% | |
| 6.1516% | |
| 9.1284% | |
| 187.6932% | |
| 319.045% | |
| 1,107.564% | |
| 21.7533% | |
| -229.4904% | |
| -149.3552% | |
| -91.9971% | |
| -14.3859% | |
| 83.5602% | |
| -47.3497% | |
| -46.7386% | |
| -52.8164% | |
| -78.6357% |